Market Cap 249.38M
Revenue (ttm) 0.00
Net Income (ttm) -62.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 694,600
Avg Vol 775,722
Day's Range N/A - N/A
Shares Out 68.14M
Stochastic %K 81%
Beta 0.71
Analysts Strong Sell
Price Target $15.00

Latest News on CRVS

Corvus Pharmaceuticals: Now At Cruising Altitude

Mar 28, 2025, 9:29 AM EDT - 4 weeks ago

Corvus Pharmaceuticals: Now At Cruising Altitude


Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?

Dec 18, 2024, 1:23 PM EST - 4 months ago

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?


Corvus Pharmaceuticals: The Market Likes The Story

Nov 13, 2024, 1:18 PM EST - 5 months ago

Corvus Pharmaceuticals: The Market Likes The Story


Corvus Pharmaceuticals Is Ready To Take Flight

Jun 20, 2024, 6:53 AM EDT - 11 months ago

Corvus Pharmaceuticals Is Ready To Take Flight


Corvus Pharmaceuticals: Ahead Of The Clinical-Stage Curve

Dec 12, 2023, 8:25 AM EST - 1 year ago

Corvus Pharmaceuticals: Ahead Of The Clinical-Stage Curve